Anti-ERK1 (phospho Y204) + ERK2 (phospho Y187) antibody (ab47339)

Publishing research using ab47339? Please let us know so that we can cite the reference in this datasheet.

ab47339 has been referenced in 2 publications.

  • Chen J  et al. GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma. Onco Targets Ther 8:3731-42 (2015). WB ; Human . PubMed: 26719701
  • Marino FE  et al. The inhibin/activin signalling pathway in human gonadal and adrenal cancers. Mol Hum Reprod 20:1223-37 (2014). PubMed: 25180271

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"